Cardiovascular risk in patients with psoriasis: JACC review topic of the week
Research suggests a possible link between vitamin B12 and lower survival rates in breast cancer
In the future, the researchers hope to clarify the long-term impact of GLP-1 medications, the HFpEF subpopulations that may derive the most benefit from them, and whether the drugs are also effective in reducing other cardiovascular risks
This is a major shift that should drive adoption. Layer that on top of easing supply constraints helped by more manufacturing capacity at least for injectables and the category starts to look less like a bottleneck and more like a funnel
While the risk of hypoglycemia is generally low with GLP-1 medications alone, this risk increases significantly when combined with insulin or sulfonylureas, often requiring dose adjustments of these agents
Disclaimer : Im an investor in Omada Health GLP-1 medications like Ozempic, Wegovy, and Zepbound are reshaping modern medicine